ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WGS vs PRVA // EV/EBITDA & P/E VALUATION

GeneDx Holdings Corp. (Class A) (NASDAQ) VS. Privia Health Group Inc. (NASDAQ) • 15-METRIC TALLY: WGS 1 — PRVA 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WGS VS. PRVA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WGS PRVA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -4.10% 10.50% -14.60 PRVA /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 68.1x — TIE /valuation <GO>
Free Cash Flow Yield 0.67% 5.82% -5.15 PRVA /fcf-yield <GO>
Operating Margin -3.10% — — TIE /operating-margins <GO>
Net Profit Margin -4.90% — — TIE /net-margins <GO>
Revenue Growth (YoY) 40.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.32 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 WGS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.5 48.9 -0.38 PRVA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 114.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.12B $2.81B -$691.5M PRVA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WGS REV PRVA REV WGS GROSS % PRVA GROSS % WGS FCF PRVA FCF
FY 2025 $427.5M $0 69.7% — $14.3M $163.4M
FY 2024 $305.4M $0 63.6% — -$34.0M $109.3M
FY 2023 $202.6M $0 — — -$180.1M $80.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WGS // BETA —
PRVA // BETA —